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RELATIONSHIP BETWEEN CONCERN FOR VISION LOSS AND SELF-CARE MANAGEMENT IN TYPE 1 AND
TYPE 2 DIABETICS
Esi W. Nkyekyer, Ron A. Adelman. Department of Ophthalmology,Yale University, School of Medicine, New Haven,
CT.
The purpose of this study is to assess the following hypotheses: concern for vision loss is associated with
self-care behavior and glucose control; concern for overall diabetes complications is associated with self-care behavior
and glucose control; concern for vision loss accounts for a significant proportion of the association between concern for
overall diabetes complications and self-care behavior and glucose control in Type 1 and Type 2 diabetic subjects.
The study sample consists of 100 participants (24 Type 1 diabetics, 69 Type 2 diabetics, 7 unknown) over
the age of 18 presenting to the Yale Diabetes Center from June 2009 to August 2009. In addition to demographic and
health-related surveys, the following questionnaires were administered: Visual Functioning Questionnaire (VFQ), Fear
of Complications Questionnaire (FCQ), and Summary of Diabetes Self-Care Activities (SDSCA) questionnaire. The
VFQItem 3 score is used to measure concern for overall eyesight (lower scores correlate with greater concern); the
FCQVision score to measure concern for potential vision loss (lower scores correlate with decreased concern); the
FCQComposite score to measure concern for overall diabetes complications (lower scores correlated with decreased
concern); and the SDSCAComposite score to measure self-care behavior (lower scores correlate with poorer self-care
behavior). Spearman Correlation analysis, Linear Regression analysis, ANCOVA and ANOVA are used to assess
relationships between VFQ, FCQ, SDSCA composite and subscale scores and HgA1c. The main outcome measures
are self-care behavior and HgA1c.
Results show that in the Type 1 Diabetes group, lower SDSCAComposite scores correlate with lower VFQItem 3
scores (rSpearman=0.521, p=0.009). The correlation is further confirmed by linear regression analysis. For the Type 2
Diabetics group, there is a statistically significant positive linear relationship between HgA1c levels and FCQVision (FLinear
(1,53) = 7.56, p = 0.008, ω=0.468) and FCQComposite scores (FLinear (1,53) = 7.80, p = 0.007, ω=0.504).
In conclusion, Type 1 diabetics with poor self-care practices are more concerned about overall eyesight and
vice versa. Type 2 diabetics with poor glycemic control have greater concern for potential vision loss and overall
diabetes complications and vice versa. This knowledge may be used to target patient education efforts to effectively
improve self-care behavior in both Type 1 and Type 2 diabetic populations. Future research is needed to investigate
factors contributing to these associations.
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1. Introduction
Diabetes is rapidly on the rise. According to national estimates for 2007, 10.7% of individuals 20
years and older and 23.1% of all people 60 years and older suffer from diabetes; at least 57 million
Americans are pre-diabetic and therefore at risk of developing diabetes and its associated
complications (1). It is well established that poor glycemic control in diabetic patients is associated
with increased risk for microvascular complications (2, 3). As such, careful management of
diabetes as a chronic disease is necessary to prevent early onset of these complications (4). This
management lies in the hands of the patient, health care professionals (primary care physicians,
internists, endocrinologists, ophthalmologists, nurses), health care institutions and policy-making
bodies. The patient is ultimately responsible for eating healthier, maintaining a normal body
weight, taking medications and monitoring glucose levels. Health care professionals play a pivotal
role in educating patients about diabetes while addressing their health care needs. Health care
institutions and policy making bodies take charge of designing cost-effective systems of
management that provide the necessary infrastructure to optimize patient care. Each level of care
faces unique challenges when addressing the continued needs of patients with chronic diseases
such as diabetes. To make productive advances in diabetes management, every facet of the
collaborative effort must work to develop creative and effective solutions to these challenges. This
is particularly important as only 7.3% of diabetic patients meet therapeutic goals for the 3 most
important measures of risk for diabetes complications: HbA1c level, blood pressure, and low-density
lipoprotein cholesterol (5).

Diabetic retinopathy is a major microvascular complication of poor glycemic control in diabetic
patients and the leading cause of new cases of blindness in the United States in persons aged 20
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to 70 years (1, 3, 6). On average, diabetic patients are more likely to suffer from correctable as well
as uncorrectable vision loss than their non-diabetic counterparts (7). Among the 10.2 million
Americans aged 40 and older with diabetes, approximately 1 in 3 have diabetic retinopathy and 1
in 12 are affected by vision threatening retinopathy (8); in all persons over the age of 18, 1 in 300
persons has diabetic retinopathy, and in 1 of 600, this retinopathy is vision-threatening (9). An
analysis by Roy et al demonstrated that 75 to 82% of persons with Type 1 diabetes have some
degree of retinopathy, and in 30 to 32% of patients, these retinal changes threaten vision (9). With
diabetes on the rise, future projections suggest that diabetic retinopathy will substantially increase
as a public health problem, particularly in the aging population (10). The number of Americans 40
years or older with diabetic retinopathy and vision-threatening diabetic retinopathy is expected to
triple by 2050, from 5.5 million to 16.0 million and from 1.2 million to 3.4 million respectively, with
increases among those 65 years or older expected to be more pronounced (2.5 million to 9.9
million for diabetic retinopathy and 0.5 million to 1.9 million for vision-threatening diabetic
retinopathy) (10).

Ophthalmologists play a significant role in screening diabetic patients for diabetic retinopathy and
providing temporizing treatments to slow progression from non-proliferative to proliferative disease.
The purpose of this study is to determine if there is any relationship between patients’ attitudes
towards diabetes-associated vision loss and their self-care behaviors. By understanding patient
attitudes and concerns about vision loss, ophthalmologists, in conjunction with primary care
physicians, nurses and other health professionals may be better positioned to substantially
influence self-care behavior in the diabetic patient population.
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a. Impact of Diabetes-Associated Vision Impairment on Diabetic Patients
Visual impairment in diabetic patients is associated with a spectrum of psychosocial sequelae often
related to the onset, progression and extent of visual loss. Bernbaum et al (11) observed that
patients with fluctuating visual impairment from diabetic retinopathy (commonly seen in the initial
stages of diabetic retinopathy) experienced greater emotional distress and depression than
patients with stable visual impairment from diabetic retinopathy. Compared with both fully-sighted
and partially-sighted diabetic patients, Cox et al found that individuals with total visual loss
experienced greater psychological distress, anxiety, and somatization (12).

Furthermore, visual impairment from diabetic retinopathy has been shown to reduce health-related
quality of life (HRQoL) measures. Lloyd et al used multiple methods (including EuroQoL (EQ-5D),
Health State Utilities Index (HUI)-3, and the National Eye Institute Visual Functioning Questionnaire
(VFQ) to estimate utility loss among patients with varying degrees of vision loss from diabetic
retinopathy. They showed that a decline in visual acuity from 20/20 to counting fingers was
significantly associated with a decrease in the majority of utility measures (13). Sharma et al in a
review of current literature examining the impact of diabetic retinopathy and diabetic macular
edema on HRQoL, amassed both qualitative and quantitative evidence for a decrease in HRQoL in
persons with diabetic retinopathy (14). Furthermore, they found evidence that laser
photocoagulation can improve health-related quality of life (14). Klein et al examined the
association between the VFQ composite and subscale scores and visual acuity, diabetic
retinopathy, and other characteristics in Type 1 diabetics. Their findings demonstrated that lower
total VFQ scores were independently associated with poorer visual acuity and more severe
retinopathy (15). Quality of life areas that are particularly affected by diabetic retinopathy and
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declining vision include independence, mobility, leisure and social interactions, and self-care
activities (16, 17).

Although the afore-mentioned studies demonstrate the impact of diabetes-associated vision loss
on HRQoL measures, a review of the literature utilizing an extensive search of PubMed yielded no
investigations into how concern for vision loss among diabetics is related to their self-management
behaviors or glycemic control.

b. Patient Attitudes Towards Diabetes-Associated Vision Loss
Type 1 and Type 2 diabetic patients have been shown to be primarily concerned about long term
complications of diabetes such as amputation, cardiovascular disease, nephropathy, neuropathy,
retinopathy and stroke (18). Loss of vision is of particular concern to a substantial proportion of the
diabetic population. In patients who have not experienced other complications of diabetes, vision
loss from diabetic retinopathy is often perceived as the most devastating complication (17). Luckie
et al assessed the presence and intensity of fear of vision loss among diabetic patients and found
37% to be preoccupied with this concern and 47.4% to have an intense fear of vision loss (19).
Furthermore, although visual acuity and the experience of previous laser treatment were predictive
of the presence of fear in Type 2 diabetics and the diabetic population as a whole, these factors
only minimally explained reported patient concern, thereby suggesting that predictors of fear of loss
of vision in the diabetic population are much more complex (19). Although a search of the literature
yielded no quantitative comparisons between fear of other diabetes complications and fear of
vision loss, Hendricks et al showed in an exploratory study that diabetic retinopathy is the most
feared long-term complication among Type 2 diabetic patients (18).
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Despite the high level of concern for vision loss, many diabetic patients do not have regular eye
examinations. Both circumstantial factors and patient attitudes to ocular screening prevent diabetic
patients from attending eye clinics for routine dilated fundoscopic examinations. Circumstantial
barriers reported in the literature include lack of health insurance, patient finances, lack of time and
inadequate access to care (20-24). Patient attitudes are often associated with a poor
understanding of diabetic retinopathy as a microvascular complication of diabetes, and can as such
affect the regularity with which patients have routine dilated fundoscopic examinations. Lewis et al
in a qualitative study of diabetic patients demonstrated that lack of awareness of the potential for
severe yet asymptomatic retinopathy was the greatest barrier to receiving eye care among diabetic
patients (23). Furthermore, fear of laser treatment and guilt about poor glycemic control deterred
patients from having regular eye examinations (23). Moss et al found that among diabetic patients
who had not had an ocular examination within the past year, the most common reasons for not
having done so were the absence of eye problems and never being told about the need for an eye
examination (22). Minority patients in particular have poor knowledge of the ocular complications
of diabetes. Among African American diabetic patients, a small proportion have heard of (36%) or
can correctly describe (8%) diabetic retinopathy, while many (79%) believe there are no effective
treatments for the disease (25). Finally, the frequency of eye examinations among Hispanic
individuals is less than the national average; only 36% of newly diagnosed diabetic patients and
52% of patients with diabetes for more than a year report knowledge of eye disease as a
consequence of diabetes, while 31% and 48% respectively know the importance of dilated eye
examinations (26). Lack of knowledge appears therefore to play a significant role in patient
attitudes towards routine ocular examinations for the detection of diabetic eye disease.
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c. The Relationship between Concern for Vision Loss and Self-Care behavior among Diabetic
Patients
Despite the considerable concern that patients have for vision loss, a search of the literature does
not reveal many investigations into the relationship between concern for vision loss and overall
self-care behavior or glycemic control among diabetic patients. Oehler et al, in a descriptive study
of diabetic patients in group therapy, observed that with deterioration of vision, diabetic patients
developed an increased awareness of the need for good glycemic control and of the risks of other
severe diabetic complications (27). Moreover, a quantitative study by Klein et al to examine the
association of the VFQ composite and specific scale scores with visual acuity, diabetic retinopathy,
and other characteristics in a cohort of persons with Type 1 diabetes, showed that better glycemic
control significantly correlated with lower vision-related concern, frustration, irritation and loss of
independence in patients with Type 1 diabetes (15). Studies investigating similar associations have
not been performed in patients with Type 2 diabetes. Additionally, the relationship between
concern for vision loss and measures of diabetes self-care activities has not been investigated.
Finally, no work has yet been done to determine how diabetic patients’ concern for vision loss
quantitatively compares to their concern for other long-term complications of diabetes, or the
proportion of the association between concern for overall diabetes complications and diabetes
health care activities/glycemic control that is accounted for by concern for vision loss alone. The
primary aim of this study is therefore to determine if there is any relationship between diabetic
patients’ concern for vision loss, their self-care behavior and level of glycemic control. The results
of such investigations could pave the way for more effective patient-centered approaches to
improving self-care behavior and disease outcomes in diabetic patients. Understanding how
patients’ concern for vision loss compares to their concern for other diabetes complications as well
as its impact on diabetes self-care activities and glycemic control could further motivate health-care
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providers focus adequate attention on this concern, thereby potentially improving self-care
behavior and health outcomes for diabetic patients.

2. Specific Hypotheses and Aims
a. Primary Aims:
i. To test the hypothesis that, concern for vision loss is associated with diabetes
self-care activities and glucose control (HgbA1c levels) in diabetic subjects.
ii. To test the hypothesis that, concern for overall diabetes complications is
associated with diabetes self-care activities and glucose control (HgbA1c levels) in
diabetic subjects.

b. Secondary Aim:
i. To test the hypothesis that, a significant proportion of the correlation between
concern for overall diabetes complications and diabetes self-care activities/glucose
control is accounted for by concern for vision loss in diabetic subjects.

In this study, concern for vision loss was divided into two components: concern for overall
eyesight which was measured using the VFQItem 3 score, and concern for potential vision
loss which was measured using the FCQVision score.

3. Methods
a. Design: This is a cross-sectional observational study of the relationship between
concern for vision loss/concern for overall diabetes complications and diabetes self-care
activities/ glycemic control in Type 1 and Type 2 diabetic subjects. The study was

8

approved as a request for exemption by the Yale University School of Medicine
Institutional Review Board.

b. Subjects: One hundred male and female diabetic subjects, over the age of 18 were
enrolled into the study. No further exclusion and inclusion criteria were defined for this
study.

c. Intake: All patients presenting to the Yale Diabetes Center for scheduled clinic visits
were approached for recruitment into the study. This process of recruitment included an
explanation of the goals of the study, the role the subject would play and an invitation to
take part in the study. Interested subjects who agreed to participate were then screened
for eligibility by being asked their age. Eligible subjects (age over 18) then completed the
interviewer-administered study assessments either before or after their scheduled clinic
visit.

d. Assessments: Study assessments include a demographic data sheet, a health
information sheet, the Visual Functioning Questionnaire (VFQ) (28), the Fear of
Complications questionnaire (FCQ) (29) and the Summary of Diabetes Self-care Activities
(SDSCA) questionnaire (30). The VFQ, FCQ and SDSCA are all questionnaires that have
been validated in the literature. All assessment tools can be found in the Appendix of this
manuscript.
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Demographic Data Sheet:
This questionnaire was used to collect the following demographic data from participants:
age, gender, language most spoken at home, race, employment status, income, marital
status and health insurance status.

Health information Sheet:
This questionnaire was adapted from a similar questionnaire used by Gwira et al in a study
of factors associated with failure to follow up after glaucoma screening in African American
patients (31). This questionnaire includes items on glucose control, diabetes
complications, and family history of diabetes and diabetes complications. Of note, patients
were asked in this questionnaire to categorize their most recent HgA1c within the past 3
months. It is this categorization that was used as the measure of glucose control in this
study.

National Eye Institute Visual Functioning Questionnaire (VFQ):
The VFQ is a questionnaire that was created to measure the components of self-reported
vision-related health status of greatest significance to individuals with chronic eye disease.
The survey assesses the impact of visual symptoms and disability on health-related quality
of life domains such as emotional well-being and social functioning. The VFQ comprises
the following subscale measures: general health, general vision, ocular pain, near
activities, distance activities, social functioning, mental health, role difficulties, dependency,
driving, color vision, and peripheral vision. Absolute composite and subscale scores on the
VFQ were converted to percentage scores as described in the VFQ manual (28). I

10

In this study, VFQItem 3 was used as a measure of concern for overall eyesight, that is
concern related to current subjective vision loss as well as concern about future potential
vision loss. Scoring of VFQItem 3 is such that lower scores indicate greater overall concern
for eyesight. The mental health subscale score (VFQMental Health) was used as a measure of
vision-associated emotional distress, with lower scores indicating greater emotional
distress. This subscale score comprises 5 core questions on concern for overall eyesight
(VFQItem 3), as well as eyesight-associated frustration (VFQItem 21), dependence (VFQItem 22),
embarrassment (VFQItem 25), and one optional question about eyesight-associated
irritability (VFQItem A12). All 5 components of the VFQMental Health score were used such that
the final VFQ survey instrument had 26 items.

Fear of Complications Questionnaire (FCQ):
The FCQ is a 15-item scale that was designed by Taylor et al to measure fear of diabetes
complications in patients with Type 1 diabetes (29). The questionnaire comprises items
related to general fears of diabetes complications, specific fears (e.g. of blindness, kidney
problems, heart disease), lifestyle fears, and fear of complications associated with poor
glucose control. Validation of the questionnaire demonstrated that it identified fear that was
a uniquely diabetes-related emotion, though moderately related to the presence of
complications and general negative affectivity. Although the original questionnaire was
scored to only obtain a composite score, in this study the questionnaire was also broken
down into the following subscale score measures: fear of long term (FCQLong term), visionrelated (FCQVision), heart-related (FCQHeart), kidney related (FCQKidney), stroke-related
(FCQStroke), peripheral vascular disease-related complications (FCQCirculation) and fear of
complications from poorly controlled blood glucose levels (FCQBlood Glucose). The absolute
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subscale and absolute composite scores were converted to percentage scores prior to
statistical analysis. The FCQ vision subscale score (FCQVision) was used as a measure of
concern for potential vision loss.

Summary of Diabetes Self-Care Activities (SDSCA) Questionnaire:
The Summary of Diabetes Self-Care Activities (SDSCA) is a brief, self-report questionnaire
of diabetes self-management that includes items assessing the following aspects of the
diabetes regimen over the previous 7 days: general diet, specific diet, exercise, bloodglucose testing, foot care, medication compliance and smoking. A revised version of the
questionnaire created by Toobert et al was used in this study (30). The measure is a
reliable and valid and found to be useful for both research and practice. The absolute
SDSCA subscale and composite scores were converted to percentage scores prior to
statistical analysis. In this study the SDSCAComposite score was the primary score of interest
and was used as a measure of overall self-care activities in diabetic patients.

e. Statistical Analysis:
All statistical analyses were performed using PASW Statistics 17 (SPSS). Data from the
questionnaires was manually entered into the SPSS program.

Pre-Study Power analysis:
Effect size estimates were computed from four papers that describe either fear of vision
loss alone or fear of overall diabetes complications, predictors of these fears and how they
impact a number of outcome variables (15, 19, 29, 32). Effect sizes were estimated per
group i.e. Type 1 and Type 2 diabetic subjects. For an effect size (correlation coefficient r)
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of 0.25 or greater, alpha of 0.05, and power of greater than 0.80, a total per group sample
size of 98 is needed. This sample will also make it possible to determine a difference
between two correlation coefficients of 0.30 or greater. Furthermore, a sample size of 98
per group will allow for an effect size (i.e. difference in questionnaire scores between Type
1 and Type 2 diabetic subjects) of 20 or greater. Given an anticipated drop-out rate of
10%, the final total number of subjects needed for enrollment is 215.

Population Comparisons:
Chi-square analysis was used to compare nominal and ordinal characteristics between
Type 1 and Type 2 diabetic subjects. Subjects with unknown diabetes status were not
included in the Chi-square analysis because the majority of expected counts for variables
studied in this group were less than 5. Independent sample Student T-test was used to
compare means of continuous variables (i.e. age, questionnaire scores) between Type 1
diabetic and Type 2 diabetic subjects. Student T-test analysis was also used to compare
VFQ, FCQ, SDSCA questionnaire scores between participants with and without diabetic
retinopathy.

Correlations:
In order to decide which type of correlation analysis, the distribution of all questionnaire
scores was analyzed using values of skewness and kurtosis. As most of the scores were
not normally distributed, Spearman correlation analysis was used instead of Pearson
correlation analysis. The majority of SDSCA subscale and composite scores had a
negatively skewed distribution. All the VFQ subscale and composite scores had negatively
skewed distributions. The FCQ composite and subscale scores were either normally
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distributed or positively skewed. Spearman correlation analysis was used to assess
relationships between VFQ, FCQ, and SDSCA subscale and composite scores. This
analysis was performed for Type 1 diabetics alone, Type 2 diabetics alone, unknown
diabetics alone and all groups combined. Given the study aims and hypotheses, the
statistical significance of the following correlations was of particular interest:
1. Correlation between VFQItem 3 score and SDSCAComposite score
2. Correlation between VFQ Mental Health score and SDSCAComposite score
3. Correlation between VFQComposite score and SDSCAComposite score
4. Correlation between FCQVision score and SDSCAComposite score
5. Correlation between FCQComposite score and SDSCAComposite score

Linear and Multiple Regression Analysis:
Linear regression analysis was used to determine the relationship between the
SDSCAComposite score as the dependent variable and VFQItem 3, VFQ Mental Health,
VFQComposite, FCQVision, and FCQComposite, and scores as the independent variables. This
was performed for Type 1 diabetics alone, Type 2 diabetics alone, unknown diabetics
alone and all groups combined. The only statistically significant relationship found was that
between VFQItem 3 and SDSCAComposite scores. Multiple regression analysis was then
performed with the other individual components of the VFQ mental health score (items 21,
22, 25, and A12) held constant to assess their impact on the linear relationship between
VFQItem 3 and the SDSCAComposite score.
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Analysis of Confounding Factors using ANCOVA:
ANCOVA was used to determine how controlling for potential confounding factors
influenced the association between VFQItem 3 and SDSCAComposite scores in the Type 1
diabetes group. The confounding factors of particular interest that were adjusted for
individually and combined together in this analysis were: age, gender, employment, marital
status, insurance, length of time with diabetes, medication type, history of diabetic
retinopathy, history of laser treatment for diabetic retinopathy and presbyopia. The
following eye-related parameters were also controlled for individually and simultaneously:
diabetic retinopathy, myopia, presbyopia, macular degeneration, cataract, glaucoma,
cataract surgery, laser therapy for diabetic retinopathy. Levene’s test for equality of
variances was used to test the null hypothesis that the error variance of SDSCAComposite
score was equal across all groups. In these analyses VFQ Item 3 was run as the covariate,
the SDSCAComposite score as the dependent variable and the confounding variables as fixed
factors. Effect sizes (ŋ2 and r) for the association between VFQItem 3 scores and
SDSCAComposite scores were also generated.

Assessing Relationship between Questionnaire Scores and HgA1c using ANOVA:
ANOVA was used to determine the relationship between HgA1c levels and VFQItem3,
VFQMental Health, VFQComposite, FCQVision, and FCQComposite scores. Planned contrasts were
used to compare mean questionnaire scores of participants in different HgA1c categories.
This analysis was performed for Type 1 diabetics alone, Type 2 diabetics alone, unknown
diabetics alone and all groups combined.
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4. Results
Population Comparisons:
A total of 100 patients (24 Type 1, 69 Type 2, 7 Unknown) were examined. Type 1 diabetic
participants were younger (mean age 44.0yrs compared to 59.2yrs; p< 0.001) and more likely to be
female (75.0%, 49.3%; χ2=4.78, p=0.029) than Type 2 diabetic participants. Type 1 diabetics were
also more likely to be employed (50.0%, 34.8%; χ2=11.6, p=0.009), less likely to be disabled
(8.30%, 18.3%; χ2=11.6, p=0.009) and less likely to be retired (8.30%, 34.8%; χ2=11.6, p=0.009)
than their Type 2 diabetic counterparts. Type 1 diabetic subjects were more likely to be single
(45.5%, 20.3%; χ2=11.7, p=0.008) and have private (54.2%, 34.8%; χ2=14.2, p=0.047) and state
(12.4%, 4.30%; χ2=14.2, p=0.047) insurance. Not surprisingly, Type 1 diabetic participants had
had diabetes for longer (greater than 20 years: 37.5%, 18.8%; χ2=27.0, p<0.001) and were also
more likely to use insulin injections (58.2%, 29.0%; χ2=45, p<0.001) and have insulin pumps
(37.5%, 0.00%; χ2=45.0, p<0.001) than their Type 2 counterparts. Of particular note was the fact
that Type 1 diabetic participants were significantly more likely to report diabetic retinopathy (62.5%,
17.4%; χ2=17.6, p<0.001) and report past laser treatment for diabetic retinopathy (41.7%, 14.5%;
χ2=7.79, p=0.005) than Type 2 participants. Type 1 participants were less likely to have presbyopia
(54.2%, 76.8%; χ2=4.43, p=0.035) (Table 1a).

There were no significant differences between Type 1 and Type 2 diabetic subjects in language
most spoken at home, race, yearly income level or highest level of education. There was no
significant difference in the distribution of HgA1c levels between the two groups. There was also no
significant difference in smoking status, the incidence of myopia, cataract, cataract surgery,
macular degeneration, glaucoma, and time of last eye examination or eye examination with
dilatation between the two groups. Furthermore, there was no significant difference in the incidence
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of diabetes-related kidney disease, stroke, heart disease, myocardial infarction, hypertension,
peripheral vascular disease, or amputation between the two groups. Finally, there was no
significant difference between the two groups with regards to family history of diabetes-associated
kidney disease, diabetic retinopathy, stroke, blindness or amputation.

With regards to questionnaire scores, there were significant differences between Type 1 and Type
2 diabetic subjects in SDSCABlood Glucose Testing, SDSCAFoot Care, and SDSCA Composite scores. On
average, Type 1 diabetics tested their blood glucose more regularly, took better care of their feet
and had better overall self-care practices than their Type 2 diabetic counterparts (Table 1b). Tables
1c – e show scores that are significantly different between patients with and without diabetic
retinopathy for all groups combined, Type 1 diabetics alone and Type 2 diabetics alone.

Correlations:
Correlation between SDSCAComposite Score and VFQItem 3 /VFQMental Health Scores:
For participants with Type 1 Diabetes, there was a statistically significant positive correlation
between the SDSCAComposite score and the VFQItem 3 score (rSpearman=0.521, N=24, p=0.009) (Table
2a). Therefore, decreased self-care behavior (↓SDSCAComposite score) was associated with greater
concern for overall eyesight (↓ VFQItem 3) and vice versa. There was also a statistically significant
positive correlation between the SDSCAComposite score and the VFQMental Health score (r=0.413, N=24,
p=0.045) (Table 2a). Therefore a decrease in level of self-care (↓SDSCAComposite) was associated
with greater vision-related emotional distress (↓ VFQMental Health) and vice versa. Correlation
analyses between SDSCAComposite score and the other four components of the VFQMental Health score
(i.e. vision-related frustration (VFQItem 21), dependence (VFQItem 22), embarrassment (VFQItem 25) and
irritability (VFQItem A12)) were individually performed. There were no significant correlations
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between the afore-mentioned score components and the SDSCAComposite score (Table 2b). As
such, VFQItem 3 alone accounts for the statistical significance of the association between visionassociated emotional distress (VFQMental Health) and self-care behavior (SDSCAComposite) (Table 2b).

For patients with Type 2 diabetes, patients with unknown diabetes type, and all patients combined
there were no statistically significant correlations between the SDSCAComposite score and VFQItem 3
nor between the SDSCAComposite score and the VFQMental Health score (Table 2c – e). Despite the
non-significance of these correlations it is interesting to note that they were all negative for these
subject groups (Table 2c – e), meaning that a decrease in self-care behavior (↓ SDSCAComposite )
was associated with less concern for overall eyesight (↑ VFQItem 3) and less vision-related
emotional distress (↑ VFQMental Health) .

Correlation between SDSCAComposite Score and FCQVision / FCQComposite Scores:
For Type 1, Type 2, Unknown and all groups combined there were no statistically significant
correlations between the SDSCAComposite score and FCQVision score nor between the SDSCAComposite
score and the FCQComposite score (Table 2a – e). As such, there was no significant association
between self-care behavior and concern for potential vision loss or between self-care behavior and
concern for overall potential diabetes complications. Despite the lack of statistical significance of
the association between SDSCAComposite and FCQVision, it is interesting to note that the correlation
was negative in the Type 1 diabetes group (r = - 0.178,N=24, p =0.404), but positive in the Type 2
(r=0.131, N= 69, p=0.285), and Unknown (r =0.182, N = 7, p = 0.696) diabetes groups and all
groups combined (r=0.08, N = 100, p = 0.381) . The correlation between SDSCAComposite and
FCQComposite, though lacking statistical significance, was negative in the Type 1 group (r = -0.359,
N=24, p =0.085) and all groups combined (r = -0.035, N=100, p= 0.727) but positive in the Type 2
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(r = 0.012, N=69, p=0.924) and unknown diabetic groups (r=0.144, N=7, p=0.75). In this instance a
negative correlation means that a decrease in self-care behavior (↓ SDSCAComposite) is associated
with an increase in concern for potential vision loss/concern for overall diabetes complications (↑
FCQVision /FCQComposite) and vice versa , while a positive correlation means that a decrease in selfcare behavior (↓ SDSCAComposite) is associated with a decrease in concern for potential vision
loss/concern for overall diabetes complications (↓ FCQVision/FCQComposite) and vice versa .

Correlation between SDSCAComposite Score and VFQComposite Score:
For Type 1, Type 2, Unknown and all groups combined there were no significant correlations
between SDSCAComposite score and VFQComposite score (Table 2 a – e). Despite the non-significance
of these correlations, it is interesting to note that for the Type 1 diabetes group, Type 2 diabetes
group, and all groups combined the correlations had a trend towards being positive (Type 1:
r=0.357, N=24, p=0.057; Type 2: r=0.022, N=69, p= 0.861; All patients: r = 0.082, N= 100, p =
0.419), while for the Unknown diabetes group the correlation was negative (Unknown: r = -0.036,
N=7, p= 0.939). In this instance a negative correlation means that a decrease in self-care behavior
(↓ SDSCAComposite) is associated with an increase in vision-related quality of life (↑ VFQComposite) and
vice versa , while a positive correlation means that a decrease in self-care behavior
(↓SDSCAComposite) is associated with a decrease in vision-related quality of life (↓ VFQComposite) and
vice versa .

Linear and Multiple Regression Analysis
Linear regression analysis demonstrated that in Type 1 diabetic subjects the concern for overall
eyesight component (VFQItem 3) of the VFQMental Health score significantly predicted self-care behavior
(β=0.118,βs=0.481, p=0.017) (Table 3a). Furthermore, 23.1% of the variance in the SDSCAComposite

19

score was predicted by the VFQItem 3 score (Table 3a, Figure 1, 2). When the other individual
components of the VFQMental Health score (items 21, 22, 25, and A12) were included in the analysis
(i.e. held constant), the strength of the relationship between VFQItem 3 and SDSCAComposite scores
increased (β=0.155, βs=0.630, p=0.018) with this model accounting for 35.7% of the variance in
SDSCAComposite score (Table 3b).

Fear of other complications of diabetes (as measured by the FCQ subscale scores) was adjusted
for using multiple regression analysis. The association between VFQItem 3 and SDSCAComposite score
in the Type 1 diabetic group became statistically insignificant when fear of long-term complications
(FCQLong-term), peripheral vascular disease (FCQCirculation) and fear of overall diabetes complications
(FCQComposite) were individually adjusted for (Table 3b). Linear regression analysis showed no
significant relationship between the VFQMental Health, VFQComposite, FCQVision and FCQComposite scores
as the predictor variables and the SDSCAComposite score as the dependent variable in the Type 1
diabetes group.

ANCOVA:
In the individual analysis of cofounding variables for the Type 1 diabetes group, the relationship
between the VFQItem 3 scores and the SDSCAComposite scores remained statistic ally significant when
all factors except for employment status (F= 2.973 (1,19), p=0.101, rVFQ Item 3 = 0.368) and diabetic
retinopathy (F = 4.274 (1,21), p = 0.051, rVFQ Item 3 = 0.411) were controlled for (Table 4). However,
the effect of employment is questionable given that the error variance of SDSCA scores across the
employment groups is not equal. Furthermore, although having diabetic retinopathy was
associated with lower SDSCAComposite scores than not having diabetic retinopathy, this association
was not statistically significant (Table1c –d). The relationship between VFQItem 3 scores and
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SDSCAComposite scores also become insignificant when all of the variables that differed significantly
between Type 1 and Type 2 diabetic groups (i.e. age, gender, employment status, marital status,
health insurance, years with diabetes, medication type, diabetic retinopathy, laser treatment,
presbyopia) were included in the analysis. The relationship remained statistically significant when
the other eye-related factors (macular degeneration, myopia, cataract, glaucoma, cataract surgery)
were individually controlled for. Furthermore, with VFQItem 3 run as a covariate and diabetic
retinopathy, myopia, presbyopia, macular degeneration, cataract, glaucoma, cataract surgery and
laser treatment for diabetic retinopathy as fixed factors, the association between VFQItem 3 and
SDSCAComposite score remained significant (F (1, 14) = 8.14, p = 0.013, rVFQ Item 3=0.500, B= 0.128)
(Table 4a).

ANOVA
ANOVA was used to determine the effect of VFQItem 3, VFQMental Health score, VFQComposite score,
FCQVision, FCQComposite and SDSCAComposite scores on HgA1c values. In the Type 2 Diabetes Group,
There was a significant effect of HgA1c on all FCQ subscale scores except FCQCirculation (Table 5b).
This effect had a significantly linear trend between HgA1c and all FCQ subscale scores (except
FCQKidney and FCQ Circulation) such that as HgA1c levels increased, the respective FCQ subscale
scores increased proportionately (Table 5b). Planned contrasts showed that for any HgA1c level >
5.9, there was an associated increase in FCQVision, FCQBlood Glucose, FCQComposite scores.
Furthermore, compared to HgA1c levels ranging from 8.0 – 8.9, HgA1c levels greater than 9.0
were associated with higher FCQComposite, FCQVision, FCQBlood Glucose, FCQLong Term, FCQStroke and
FCQHeart scores. Calculation of individual model effect sizes (ω) and contrast effect sizes (r)
showed that the association between FCQVision and HgA1c had the third largest effect size,
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preceded only by the association between HgA1c and FCQComposite and FCQBlood Glucose
scores respectively (Table 5b, 5c).

For all groups combined, there was a significant effect of HgA1c on FCQComposite, FCQ Blood Glucose
and FCQStroke scores (Table 5b). However, this effect was only significantly linear between HgA1c
and all FCQBlood Glucose scores, such that as HgA1c levels increased, the FCQBlood Glucose score
increased proportionately (Table 5b). Planned contrasts showed that compared to HgA1c levels
ranging from 8.0 – 8.9, HgA1c levels >9.0 were associated with higher FCQComposite, FCQBlood Glucose
and FCQStroke scores. Calculation of individual model effect sizes (ω) and contrast effect sizes (r)
demonstrated that the association between FCQBlood Glucose and HgA1c had the largest effect size,
followed by the association between HgA1c and FCQStroke and FCQ Composite scores respectively
(Table 5b, 5c).

No significant effect between HgA1c and FCQ Composite and subscale score was found for the
Type 1 diabetes group. Furthermore, for the Type 1 diabetes group, Type 2 diabetes group and all
groups combined no statistically significant effects of HgA1c values on VFQItem 3, VFQMental Health,
and VFQComposite scores respectively were determined.

5. Discussion
Type 1 Diabetes Group
This study has demonstrated that in Type 1 diabetics, self-care behavior (SDSCAComposite) is
negatively correlated with concern for overall eyesight (VFQItem 3) but not significantly associated
with concern for potential vision loss (FCQVision). The correlation between self-care behavior and
concern for overall eyesight becomes statistically insignificant when diabetic retinopathy and
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employment status are individually adjusted for, and when demographic variables that differ
significantly between the Type 1 and Type 2 diabetic groups are controlled for simultaneously.
Furthermore, individually adjusting for fear of overall complications (FCQComposite), long-term
complications (FCQLong-term) and peripheral vascular disease (FCQCirculation) causes the linear
relationship between concern for overall eyesight and self-care behavior to become statistically
insignificant. Linear regression analysis confirms the correlation between concern for overall
eyesight as a predictor variable and self-management behavior as the dependent variable,
however causality cannot be proved from these results. It is therefore possible that concern for
overall eyesight, either because of current subjective vision loss or future potential vision loss,
generates a mentality in Type 1 diabetic patients that results in poorer self-care behavior.
However, it is more plausible that Type 1 diabetics with poor self-care behavior are simply more
concerned about overall eyesight because of their awareness of the consequences of inadequate
self-management practices, or because they already have diabetes-related eye disease that they
know can be worsened by their poor self-care behavior.

In the Type 1 diabetes group, there were no statistically significant relationships between concern
for overall diabetes complications (FCQComposite) and self-care behavior (SDSCAComposite), or
between HgA1c values and self-care behavior (SDSCAComposite), concern for overall eyesight
(VFQItem 3), vision-associated emotional distress (VFQMental Health ) and concern for overall diabetes
complications (FCQComposite) respectively. Although there was a negative correlation between selfcare behavior and vision-associated emotional distress (VFQMental Health) in the Type 1 diabetes
group, concern for overall eyesight (VFQItem 3) was the only one of the five components of the
VFQMental Health score that significantly contributed to this correlation; the other four components of
the VFQMental Health score did not individually contribute in a statistically significant manner to this
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correlation (Table 2a). As such, the VFQMental Health score can essentially be equated to the VFQItem 3
score when describing the relationship between SDSCAComposite and VFQMental Health.

Given the absence of a statistically significant relationship between concern for potential vision loss
(FCQVision) and self-care behavior (SDSCAComposite), it is possible that there are elements of concern
for overall eyesight (VFQItem 3) that are not measured by the FCQVision score but are associated with
self-care behavior. This is supported by the observation that although FCQVision and VFQItem 3 are
positively correlated (Table 2b), the correlation coefficient is less than 1. Since FCQVision measures
concern for potential vision loss, one can speculate that concern for current subjective vision loss
accounts for a significant proportion of the relationship between concern for overall eyesight
(VFQItem 3) and self-care behavior in the Type 1 diabetes group. It would not be surprising if this
were indeed the case, since 62.5% of subjects in the Type 1 diabetes group reported having the
diagnosis of diabetic retinopathy(Table 1a), and are as such more likely to be concerned about
current subjective vision loss than they are about potential future vision loss.

The validity of the effect of employment on the relationship between self-care behavior and
concern for overall eyesight is questionable, particularly since the error variance of SDSCAComposite
scores across the employment categories is not equal. Nonetheless, further analysis of the data
shows that both employed and unemployed members of the Type 1 diabetes group have
significantly better self-care behavior than their disabled counterparts. ‘Disabled’ in this context
refers to participants on social security disability insurance who are unable to work because of
medical conditions spanning all organ systems. Selby et al (33) have demonstrated that lower
income and lower general health status are associated with poor self-care behavior and poorly
controlled diabetes (i.e. HgA1c >8%, systolic blood pressure > 140 mmHg and LDL-cholesterol >
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130 mg/dL). It is therefore conceivable that subjects who are employed have greater financial
resources and fewer physical impediments than their disabled counterparts, thereby enabling them
to better adhere to self-management practices. The same can be said for unemployed subjects
who may not be as well equipped financially as their employed counterparts, but are more likely to
be physically able to comply with self-care activities than their disabled counterparts. Employment
status presumably accounts for a substantial proportion of the self-care behavior of Type 1
subjects in this study such that adjusting for it minimizes the observed interaction between concern
for overall eyesight and self-management behavior and makes the association statistically
insignificant.

To further understand the impact of diabetic retinopathy on the relationship between self-care
behavior and concern for overall eyesight, it is interesting to note that the presence of diabetic
retinopathy is associated with lower SDSCAComposite scores (i.e. poorer self-care behavior) in the
Type 1 diabetic group though not in a statistically significant manner (Table 1d). Furthermore,
diabetic retinopathy is associated with lower VFQMental Health scores (i.e. greater concern for overall
eyesight) in a statistically significant manner among Type 1 diabetic participants (Table 1d). Klein
et al (15) have shown a statistically significant correlation between severity of diabetic retinopathy
and concern for overall eyesight (as measured using the VFQMental Health score): less severe diabetic
retinopathy was associated with less concern for overall eyesight while more severe diabetic
retinopathy was associated with greater concern for overall eyesight. Given the relationship
between diabetic retinopathy and concern for overall eyesight in the Klein study as well as the
potential association between diabetic retinopathy and self-care behavior in this study, it is very
probable that the relationship between concern for overall eyesight and self-care behavior is
substantially attributable to the presence of diabetic retinopathy in Type 1 diabetics. This is further
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supported by the fact that adjusting for other eye-related factors (i.e. macular degeneration,
myopia, presbyopia, cataract, glaucoma, cataract surgery, laser therapy) had no effect on the
statistical significance of the relationship between concern for overall eyesight and self-care
activities. A larger sample size may however be required to prove the statistical significance of the
association between diabetic retinopathy and self-care behavior to further support this explanation.

In this study no significant correlation between concern for overall diabetes complications
(FCQComposite) and self-care behavior (SDSCAComposite) nor between concern for potential vision loss
(FCQVision) and self-care behavior were demonstrated in the Type 1 diabetes group. As such it is
not possible to determine what proportion of the correlation between concern for overall diabetes
complications and diabetes self-care behavior is accounted for by concern for overall eyesight or
concern for potential vision loss in Type 1 diabetic participants. Nonetheless the individual effects
of concern for overall, long-term and peripheral vascular complications (FCQComposite, FCQLong-term,
and FCQCirculation scores respectively) on the significance of the linear relationship between concern
for overall eyesight (VFQItem 3) and self-care behavior (SDSCAComposite) ,suggest that these
concerns contribute in such a way as to make the negative relationship between self-care behavior
and concern for overall eyesight statistically insignificant. For instance, it is possible that better selfcare behavior is associated with greater concern for the afore-mentioned categories of
complications therefore canceling out the effect of self-care behavior on concern for overall
eyesight. The associations between self-care behavior and concern for overall diabetes
complications and between self-care behavior and concern for potential vision loss respectively
may be better evaluated in a larger sample population of Type 1 diabetic participants.
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There is evidence in the literature to suggest that diabetic patients with deteriorated vision develop
an increased awareness of the need for good glycemic control and the risks of other diabetic
complications (27). As has been demonstrated in the literature, one would expect increased
awareness or education about diabetes complications and management to result in an
improvement in self-care behavior and glycemic control (34-37). However, in this study, there is no
statistically significant difference in SDSCAComposite score between Type1 diabetic patients with and
without diabetic retinopathy (Table 1d). This discrepancy therefore suggests that there are
elements associated with having diabetic retinopathy that prevent our study population of Type 1
diabetics from taking better care of themselves. In this study, Type 1 diabetic subjects with
diabetic retinopathy had a longer duration of diabetes than their counterparts without diabetic
retinopathy (73.3% reported 20 or greater years of diabetes compared to 44.4% of subjects without
diabetic retinopathy). Both Eiser et al and Shah et al have demonstrated that diabetic patients with
longer disease duration are more reluctant to change their self-management practices ((38, 39).
As such, it is possible that despite the likely increase in awareness of diabetes complications
among subjects with diabetes-associated vision loss, resistance to change yields poor self-care
behavior I this population.

Although the primary hypotheses of this study did not specify the expected direction of the
relationship between concern for overall eyesight and self-care behavior, the negative correlation
between these two variables highlights a significant discrepancy between patients’ health-related
beliefs and behaviors regardless of the direction of the relationship. If poorer self-care behavior
predicts greater concern for overall eyesight, then patients’ concern for overall eyesight most likely
arises from awareness of the consequences of their poor self-care practices. If on the other hand,
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greater concern for overall eyesight predicts poorer self-care behavior, disempowering attitudes
towards self management, such as decreased sense of self-efficacy (i.e. perceived capability to
change behavior) and anxiety may be at play. In this age of rising prevalence of chronic disease,
there has been a concomitant response in the redesign of primary care systems to improve
management and outcomes of long-term illness(40-45). Motivational interviewing has come to the
forefront as an effective way of helping health systems (at the clinician-patient level) deliver
integrated chronic disease care while empowering patients to effectively self-manage their longterm diseases (45).

Motivational interviewing is a ‘client centered directive method of enhancing intrinsic motivation to
change by exploring and resolving ambivalence’ (46). The principles of the motivational
interviewing approach are captured by the alliterations: Express Empathy; Develop Discrepancy;
Roll with Resistance; Support Self Efficacy, and the acronym R.U.L.E: Resist the righting reflex;
Understanding your patient’s dilemma and motivations; Listen to and Empower your patients (46,
47). Motivational interviewing is currently utilized by clinicians to successfully improve patient
outcomes in a wide range of settings including diabetes management. For instance, in teenagers
with Type 1 diabetes, motivational interviewing was shown in a multicenter randomized controlled
trial by Channon et al to result in lower HgA1c levels as well as better psychosocial measures (e.g.
more positive well-being and improved quality of life) than their counterparts who received support
visits (48). In patients with newly diagnosed Type 2 diabetes, Brug et al found a significant
reduction in saturated fat intake and increase in fruit intake among patients of dieticians trained in
motivational interviewing (49).
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Motivational interviewing could be used to effectively address the ambivalence identified in this
study between participants’ concern for overall eyesight and self-care behavior. The presence of
such ambivalence suggests that there are factors in the lives of these Type 1 diabetic patients that
have (from the perspective of the participants) a more compelling risk-benefit ratio than the selfmanagement practices that could improve their disease profile. For instance, one might imagine a
Type 1 diabetic subject voicing ambivalence in the following way: ‘I want to control my diabetes to
prevent (further) damage to my eyes. However if I exercise I am more likely to become
hypoglycemic.’ or ‘I want to control my diabetes to prevent (further) damage to my eyes. However,
cooking healthy meals takes up time that I could use watching television.’ Motivational interviewing
could be used by all level clinicians (physicians, nurses, ophthalmologists etc) to help Type 1
diabetics unearth such ambivalence and create avenues for patients’ active participation in finding
practical ways of resolving this ambivalence and improving self-care behavior.

Type 2 Diabetes Group
ANOVA analysis demonstrated positive linear associations between HgA1c levels and concern for
overall diabetes complications (FCQComposite), concern for potential vision loss (FCQVision), concern
for complications from poorly controlled blood glucose (FCQBlood Glucose), concern for long-term
diabetes complications (FCQLong Term), concern for heart disease (FCQHeart), and concern for stroke
(FCQStroke) respectively in the Type 2 diabetes group. Based on effect size calculations, concern
for potential vision loss (FCQVision) was the second most likely specific concern to be associated
with HgA1c levels; concern for complications from poorly controlled blood glucose levels (FCQBlood
Glucose)

was the most likely specific to be associated with HgA1c levels. There was no statistically

significant association between concern for overall eyesight (VFQItem 3) and HgA1c levels.
Furthermore, in the Type 2 diabetes group, there were no statistically significant associations
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between self-care behavior (SDSCAComposite) and concern for overall eyesight (VFQItem 3), self-care
behavior and concern for potential vision loss (FCQVision), or self-care behavior and concern for
overall diabetes complications (FCQComposite). In this instance also, it is not possible to prove
causality. As such participants with high HgA1c scores could be more concerned about potential
vision loss, overall diabetes complications or other specific complications because of their
awareness of the consequences of poorly controlled glucose levels. Though less plausible, it is
also possible that participants with high levels of concern about potential vision loss, overall
diabetes complications or other specific complications have poorly controlled glucose levels
because of high stress or anxiety or poor self-care behavior resulting from high stress or anxiety.

Despite the association between concern for potential vision loss and HgA1c and between concern
for overall diabetes complications and HgA1c, there was no statistically significant relationship
between self-care behavior and HgA1c. As in other studies in the literature (34-37) , one would
have expected self-care behavior to positively correlate with glycemic control. It is likely that in this
study where HgA1c was categorized and not measured as a continuous variable, statistical
analysis performed to determine the relationship between self-care behavior and glycemic control
was less reliable. It is also conceivable that better glycemic control is associated more with
interventions that occur in the clinic setting (e.g. medication changes to improve hyperglycemia)
than with the participants’ own self-management practices. Furthermore, this is a study in which
self-care behavior was assessed by participants’ self-reported perception of their health behavior.
As such varying levels of awareness of best self-care practices may have caused participants to
both over- and under-estimate the degree to which they were in fact managing their own health.
The balancing out effect of educational awareness on self-care trends may explain the absence of
a statistically significant relationship between self-care behavior and HgA1c. Finally, although
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current research suggests that the strength and direction of the relationship between stress and blood
glucose control varies considerably between individuals (50, 51), there is evidence to suggest that

recent severe stressors are associated with poorer glycemic control (52) and that stress
management training can improve glycemic control (53). It is therefore possible that increased fear
of overall diabetes complications induces a stress response that perpetuates poorly controlled
blood glucose levels and worse HgA1c values therefore decreasing the impact of adherence to
self-care practices.

Looking at the results obtained in this study, it is possible to say that Type 1 diabetics are
concerned about overall eyesight because of poor self-care behavior and high incidence of diabetic
retinopathy, while Type 2 diabetics are concerned about potential vision loss and overall diabetes
complications because of their awareness of poor glycemic control. If better self-care behavior
does indeed predict good glycemic control, it can be inferred for the Type 2 diabetes group that
poorer self-management behavior is associated with increased concern for vision loss and overall
diabetes complications. Given this potential incongruence between health care beliefs and
behavior, motivational interviewing could also be effectively used to increase Type 2 diabetic
patient involvement in self-management practices.

All Groups Combined
In this study, there were no statistically significant relationships between concern for overall
eyesight, concern for potential vision loss and self-care behavior or glycemic control (HgA1c) for all
groups combined. The statistically significant associations demonstrated between HgA1c and
FCQComposite, FCQBlood Glucose and FCQStroke scores respectively are most likely the result of
combining the associations seen in the Type 1 and Type 2 diabetic groups alone.
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Study Limitations:
This study has a number of limitations. The predicted sample size for this study was 215. However,
only 100 subjects were enrolled. This discrepancy is primarily due to the fact that after one month
of recruiting participants for this study at the Yale Diabetes Center, the proportion of patients
presenting to the clinic who had already completed the study increased substantially. With a less
than optimum sample size, it is not possible to conclude with confidence that the study yielded all
the statistically significant results that it had the potential for. Furthermore, given the numerous
statistically significant demographic and health-related differences between the Type 1 and Type 2
diabetes groups, there were many potential sources of confounding. However, the small sample
size made it difficult to control for different combinations of all the potential confounding variables
without decreasing the power of the study. As such only individual adjustments for confounding
variables on the relationship between concern for vision loss and self-management behavior were
considered as truly reliable. A larger sample size would make it possible to control for different
combinations of the confounding variables to further unveil any synergistic effects they may have
on the outcomes of interest in this study.

All the participants surveyed were patients at the Yale Diabetes Center. Patients who are cared for
in a diabetes clinic are not necessarily representative of the broad spectrum of diabetes patients.
This sampling framework may therefore reduce the generalizability of the results obtained.
According to 2004 to 2006 national survey data for people ages 20 years or older, 6.6 percent of
non-Hispanic whites, 7.5 percent of Asian Americans, 10.4 percent of Hispanics, and 11.8 percent
of non-Hispanic blacks had diagnosed diabetes (54). In New Haven County 69.9% of the
population is non-Hispanic White, 13.0% is black, 13.3% is Hispanic and 3.5% is Asian (55).
Inferring from this data, one would expect the racial distribution among diabetic patients attending
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the Yale Diabetes Clinic to be as follows: 60% non-Hispanic white, 19% black, 18% Hispanic, and
4% Asian. The population sample in this study therefore has a greater representation of whites
(63%) and blacks (21%) and a smaller representation of Hispanics (10%) and Asians (2%) than
expected. Furthermore, since care of diabetic patients occurs in diverse contexts, participants
could have also been recruited from general practices, community centers etc to allow for better
representation as well as comparison of various diabetes care contexts. Finally, a control group of
non-diabetic subjects was not utilized in this study. The presence of a non-diabetic control group
would have allowed for comparison of health beliefs and behaviors between members of the
general population and diabetic subjects.

All questionnaires in this study were interviewer-administered. To allow for more accurate
answering of questionnaires, it may have been better to a give participants the opportunity to
complete the questionnaires on their own. This is particularly pertinent to the SDSCA questionnaire
- a measure of self-care behavior over the previous 7 days. The predominantly negative skew of
the SDSCA composite and sub-scale score distributions could be due to participants’ desire to
please the interviewer. The fact that a 100% medication compliance rate was measured among all
100 subjects further highlights the way in which this ‘desire to please the interviewer’ could have
influenced the responses to interviewer-administered questionnaires. Furthermore, although the
format for administering the questionnaires was standardized, the likelihood of interviewer bias is
high particularly since the interviewer was also responsible for analyzing the data collected.

Baseline mental health conditions were neither measured nor adjusted for in this study. ‘Concern’
for overall eyesight and ‘fear’ of overall and specific diabetes complications are multi-faceted
psychosocial constructs. Mental health states such as depression and anxiety could therefore have
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influenced the way in which participants answered the afore-mentioned questionnaires. For
instance, participants with greater baseline anxiety may have exhibited greater concern for overall
eyesight and fear of diabetes complications. Furthermore, there is evidence in the literature
demonstrating that greater severity of depression symptoms is associated with poorer diet and
medication regimen adherence and functional impairment in diabetic patients (56). As such mental
health states such as depression could also have affected the way in which participants answered
the SDSCA questionnaire. Anxiety and depression could have been measured using
questionnaires such as the Hospital Anxiety and Depression (HAD) scale (57), and adjusted for
accordingly in the study analyses.

In this study, all health information including HgA1c values within the previous 3 months was
determined from participants’ reports and was therefore subject to substantial recall error. To
standardize and increase the accuracy of the process of acquiring HgA1c data, participants’ HgA1c
could have been tested at the time of completion of the questionnaires using an instant, point-ofcare HgA1c measuring instrument. This method would have yielded continuous HgA1c values that
could have then been easily used in correlation and regression analysis to obtain more reliable
results. Along the same lines, information such as diabetes type, as well as the presence and
severity of eye ailments (e.g. diabetic retinopathy, glaucoma, cataract etc) could have been
confirmed either by examination of the participants or chart review. By depending on participants
for provision of health information, one assumes that they are actively involved in and
knowledgeable about their health when this may not necessarily be the case.

Visual acuity of participants was not determined in this study. Nonetheless, the VFQComposite score
has been shown to be significantly correlated with visual acuity such that higher scores are
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associated with better visual acuity (15). In this study, independent sample T-test analysis showed
no significant differences in VFQComposite scores between Type 1 and Type 2 diabetes groups
thereby suggesting that there were no significant differences in visual acuity. However, given the
multi-faceted nature of the VFQComposite score, it was not in fact used in this study as a measure of
visual acuity. To better isolate the effect of visual acuity on the relationship between concern for
vision loss and self-care behavior, a direct and objective measure of visual acuity would have been
more effective.

Although the educational level of participants was accounted for in this study, knowledge of
diabetes was not specifically measured. According to a study by Osborn et al, having more
knowledge about diabetes independently and directly predicted better self-care behavior; better
self-care behavior predicted improved glycemic control (58). Given the afore-mentioned findings, it
is conceivable that participants’ level of diabetes knowledge is a factor that needs to be controlled
for in order to better evaluate the relationship between concern for vision loss and self-care
behavior. This is especially important since prior studies have shown that only a small proportion of
diabetic patients are actually aware of diabetic retinopathy as a complication of diabetes (25, 26) –
a fact that further begs the question of whether patients can be concerned about vision loss when
they are not aware of the problem of diabetic eye disease. Validated measures of diabetes
knowledge include the Diabetes Knowledge (DKN) Scale (59) and the 24-item Diabetes
Knowledge questionnaire (60), either of which could have been included in the questionnaire
packet utilized in this study.

One of the goals of this study was to test the hypothesis that a significant proportion of the
correlation between concern for overall complications and diabetes self-care activities/ glycemic
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control is accounted for by concern for overall eyesight/potential vision loss in diabetic subjects.
However, the measures for concern for overall eyesight (VFQItem 3) and concern for overall diabetes
complications (FCQComposite) were derived from two distinct and separately validated
questionnaires. As such, had there been statistically significant correlations between self-care
behavior and concern for vision loss and self-care behavior and concern for overall diabetes
complications respectively, it would not have been possible to accurately determine what
proportion of the latter correlation was accounted for by the former. To make the comparison
plausible, the measure of concern for vision loss would have ideally been a subscale score of a
questionnaire measuring overall concern for diabetes complications. For the Type 2 diabetic group
in which statistically significant relationships were demonstrated between FCQVision and HgA1c and
FCQComposite and HgA1c in the Type 2 diabetes group, the effect sizes are a useful way of
comparing the strength of the associations between FCQ subscale scores and HgA1c but not for
determining the proportion of the relationship between FCQComposite and HgA1c that they
account for. Although FCQ subscale scores were calculated in this study, the FCQ was not
designed to have these subscale scores and as such is not be the most appropriate questionnaire
for determining the proportion of the correlation between concern for overall complications and
diabetes self-care activities that is accounted for by concern for vision loss. A more suitable study
instrument would therefore have to be designed and validated for this purpose.
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6. Conclusions
Poorer self-care behavior is associated with greater concern for overall eyesight and vice versa in
Type 1 diabetics. Adjusting for diabetic retinopathy and employment status individually affect the
statistical significance of this relationship. The incongruence between health care attitudes
(concern for overall eyesight) and behaviors (diabetes self-care activities) can be targeted by
health care providers using interventions such as Motivational Interviewing to promote active
participation of this diabetic population in finding practical ways of resolving this ambivalence and
improving self-care behavior. In Type 2 diabetic subjects, higher HgA1c levels are associated with
increased concern for potential vision loss and increased concern for overall diabetes
complications and vice versa. However, there is no statistically significant relationship between
self-care behavior and glycemic control. Future studies to better understand the factors driving the
afore-mentioned associations could result in the creation of new models of care or support the
implementation of already existing models of care for better health outcomes in the diabetic
population.
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7. Tables
Table 1a. Population Comparisons - Chi-Square Analysis of Demographic Characteristics of Type 1 and
Type 2 Diabetes Groups.

Type 1 DM

Type 2 DM

Chi Square (χ2) Significance
(2-tailed)#

Gender
Female

18 (75.0%)

34 (49.3%)

Male

6 (25.0%)

35 (50.7%)

Employment Status
Employed

12 (50.0%)

24 (34.8%)

Unemployed

8 (33.3%)

8 (11.6%)

Disabled

2 (8.30%)

13 (18.8%)

Retired

2 (8.30%)

24 (34.8%)

Marital Status
Single

11 (45.8%)

14 (20.3%)

Married

13 (54.2%)

34 (49.3%)

Divorced

0 (0.00%)

14 (20.3%)

Other

0 (0.00%)

7 (10.1%)

Health Insurance
Medicare Only

1 (4.2%)

11 (15.9%)

Medicaid Only

2 (8.30%)

13 (18.8%)

Private Only

13 (54.2%)

24 (34.8%)

Medicare and

1 (4.20%)

3 (4.30%)

Medicare and Private

2 (8.30%)

14 (20.30%)

Medicaid and Private

2 (8.30)

0 (0.00%)

Federal/State

3 (12.5%)

3 (4.30%)

None

0 (0.00%)

1 (1.40%)

4.78

0.029

11.7

0.009

11.7

0.008

14.2

0.047

16.1

<0.001

Medicaid

Years with DM
Less than 20 years

9 (37.5%)

56 (81.2%)
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Great than 20 years

15 (62.5%)

13 (18.8%)

Medication Type
Pills/Tablets

0 (0.00%)

22 (31.9%)

Insulin (Injection)

14 (58.3%)

20 (29.0%)

Insulin (Pump)

9 (37.5%)

0 (0.00%)

Pills/Tablets and

1 (4.20%)

24 (34.8%)

0 (0.00%)

3 (4.30%)

45.0

<0.001

17.6

<0.001

7.79

0.005

4.43

0.035

Insulin
None
Diabetic
Retinopathy
Yes

15 (62.5%)

12 (17.4%)

No

9 (37.5%)

57 (82.6%)

Laser Treatment
Yes

10 (41.7%)

10 (14.5%)

No

14 (58.3%)

59 (85.5%)

Presbyopia
Yes

13 (54.2%)

53 (76.8%)

No

11 (45.8%)

16 (23.2%)

#Only

statistically significant distribution differences are here reported

Table 1b. Population Comparisons - Differences in Questionnaire Scores Between Participants with Type
1 and Type 2 Diabetes
Variable

Type 1 DM

Type 2 DM

T-test value

Significance
(2- tailed)#

Age (yrs)

44.0 (±14.2)

59.2 (± 13.2)

-4.76

<0.001

SDSCA blood sugar testing (%)

97.0 (± 8.66)

80.1 (±30.5)

4.10

<0.001

SDSCA foot care (%)

85.7 (±18.0)

71.1 (± 31.6)

2.76

0.007

SDSCA Composite (%)

78.1 (±9.50)

70.2 (±17.4)

2.84

0.006

#Only

statistically significant differences in scores are here reported.
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Table 1c. Differences in Questionnaire Scores Between Participants with and without Diabetic Retinopathy
(All Groups Combined)

Variable (± SD)

Diabetic Retinopathy

Diabetic Retinopathy

T-test

Significance

(Yes)

(No)

value

(2-tailed)

FCQLong term

66.3 ± 28.0

51.8 ± 29.3

2.22

0.028*

FCQVision

54.3 ± 34.5

36.5 ± 31.6

2.44

0.017*

FCQKidney

44.0 ± 33.7

27.2 ± 32.1

2.29

0.024*

FCQComposite

52.6 ± 25.2

41.9 ± 26.0

1.84

0.068

SDSCABlood Glucose

95.0 ± 13.4

81.4 ± 29.9

3.12

0.002*

SDSCAFoot Care

85.7 ± 19.3

71.9 ± 31.2

2.64

0.010*

SDSCAComposite

74.2 ± 10.6

71.4 ± 17.5

0.785

0.434

VFQGeneral Vision

66.7 ± 24.8

80.0 ± 14.9

-2.62

0.013*

VFQNearActivities

76.9 ± 28.6

90.9 ± 16.3

-2.40

0.022*

VFQDistant Activities

77.2 ± 28.1

92.4 ± 11.5

-2.74

0.010*

VFQMental Health

76.3 ± 28.5

90.3 ± 9.87

-2.51

0.018*

VFQRole Difficulties

78.2 ± 33.4

92.3 ± 18.1

-2.08

0.046*

VFQDependency

82.7 ± 29.4

98.3 ± 7.47

-2.72

0.011*

VFQColor Vision

85.2 ± 24.3

97.6 ± 12.6

-2.53

0.016*

VFQComposite

79.8 ± 23.3

91.8 ± 8.51

-2.63

0.014*

VFQItem 3

47.2 ± 38.8

62.3 ± 30.1

-2.06

0.042*

VFQItem 21

76.9 ± 38.6

96.2 ± 15.4

-2.54

0.012*

VFQItem 22

77.8 ± 37.6

95.5 ± 14.6

-2.39

0.023*

VFQItem 25

87.0 ± 28.1

99.7 ± 2.93

-2.33

0.028*

*Statistically

significant difference in scores between diabetic subjects with and without diabetic retinopathy

(all groups combined)
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Table 1d. Differences in Questionnaire Scores Between Participants with and without Diabetic Retinopathy
(Type 1 Diabetes Group only)
Diabetic Retinopathy

Diabetic Retinopathy

T-test

Significance

(Yes)

(No)

value

(2-tailed)

Variable (± SD)

*

FCQVision

54.4±31.2

25.9±22.2

2.40

0.026*

SDSCAExercise

99.0±3.70

93.7±13.1

-3.26

0.004*

SDSCAComposite

75.7 ±8.72

82.3 ±8.78

-1.79

0.087

VFQDistant Activities

76.1±30.5

95.4±11.1

-2.21

0.039*

VFQRole Difficulties

77.5±33.1

100.0±0.0

-2.63

0.02*

VFQMental Health

74.0±28.1

93.3±6.1

-2.57

0.021*

VFQDependency

81.1±30.6

100.0±0.0

-2.39

0.031

VFQDriving

72.2±33.8

98.3±3.7

-2.64

0.022*

VFQColor Vision

86.7±20.8

100.0±0.0

-2.48

0.027*

VFQPeripheral Vision

80.0±33.0

100.0±0.0

-2.35

0.034*

VFQComposite

79.6±23.7

96.6±3.0

-2.74

0.015*

VFQItem 3

41.7±38.6

66.7±30.6

-1.65

0.113

VFQItem 21

75.0±40.1

100.0±0.0

-2.42

0.030*

VFQItem 22

75.0±40.1

100.0±0.0

-2.42

0.030*

Statistically significant differences in scores between diabetic subjects with and without diabetic retinopathy

(Type 1 diabetes group).

Table 1e. Differences in Questionnaire Scores Between Participants with and without Diabetic Retinopathy
(Type 2 Diabetes Group only)

Variable

Diabetic Retinopathy

Diabetic Retinopathy

T-test

Significance

(Yes)

(No)

value

(2-tailed)#

FCQKidney

48.1±38.9

26.3±32.2

2.06

0.044

SDSCAFoot Care

85.7±19.0

68.0±33.0

2.52

0.018

#Only

statistically significant differences in scores are here reported.
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Table 2a. Significant and non-significant Spearman Correlations of Interest for the Type 1 Diabetic Group
(N= 24)

Spearman's rho

VFQ Item 3
.521**

VFQ
Mental
Health
Score
.413*

VFQ
Composite
Score
0.393

FCQ
Vision
Score
-0.178

FCQ
Composite
Score
-0.359

.

0.009

0.045

0.057

0.404

0.085

SDSCA
Composite
score
1.000

SDSCA
Composite
score

Correlation
Coefficient

VFQ Item 3

Correlation
Coefficient

.521**

1.000

.967**

.610**

-.483*

-.556**

Sig. (2tailed)

0.009

.

0.000

0.002

0.017

0.005

VFQ
Mental
Health
Score

Correlation
Coefficient

.413*

.967**

1.000

.682**

-.530**

-.550**

Sig. (2tailed)

0.045

0.000

.

0.000

0.008

0.005

VFQ
Composite
Score

Correlation
Coefficient

0.393

.610**

.682**

1.000

-0.274

-0.356

Sig. (2tailed)

0.057

0.002

0.000

.

0.195

0.088

FCQ
Vision
Score

Correlation
Coefficient

-0.178

-.483*

-.530**

-0.274

1.000

.679**

Sig. (2tailed)

0.404

0.017

0.008

0.195

.

0.000

FCQ
Composite
Score

Correlation
Coefficient

-0.359

-.556**

-.550**

-0.356

.679**

1.000

Sig. (2tailed)

0.085

0.005

0.005

0.088

0.000

.

Sig. (2tailed)

* Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
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Table 2b. Spearman Correlation between VFQMental Health Score components and SDSCAComposite Score in the
Type 1 Diabetes Group (N = 24).

SDSCA
Composite
Score
1.000

VFQItem 3
.521**

VFQItem 21
0.025

VFQItem 22
0.020

VFQItem 25
0.066

VFQItem A12
-0.110

VFQ Mental
Health
Score
.413*

.

0.009

0.908

0.926

0.758

0.609

0.045

Correlation
Coefficient

.521**

1.000

.565**

.565**

.472*

0.363

.967**

Sig. (2tailed)

0.009

.

0.004

0.004

0.020

0.082

0.000

Correlation
Coefficient

0.025

.565**

1.000

.993**

.829**

.703**

.716**

Sig. (2tailed)

0.908

0.004

.

0.000

0.000

0.000

0.000

Correlation
Coefficient

0.020

.565**

.993**

1.000

.835**

.710**

.719**

Sig. (2tailed)

0.926

0.004

0.000

.

0.000

0.000

0.000

Correlation
Coefficient

0.066

.472*

.829**

.835**

1.000

.816**

.646**

Sig. (2tailed)

0.758

0.020

0.000

0.000

.

0.000

0.001

-0.110

0.363

.703**

.710**

.816**

1.000

.551**

Sig. (2tailed)

0.609

0.082

0.000

0.000

0.000

.

0.005

Correlation
Coefficient

.413*

.967**

.716**

.719**

.646**

.551**

1.000

Sig. (2tailed)

0.045

0.000

0.000

0.000

0.001

0.005

.

Spearman's rho
SDSCA
Composite
Score

Correlation
Coefficient

Sig. (2tailed)

VFQItem 3

VFQItem 21

VFQItem 22

VFQItem 25

VFQItem A12

VFQ
Mental
Health
Score

Correlation
Coefficient

* Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
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Table 2c. Significant and non-Significant Spearman Correlations of Interest for the Type 2 Diabetic Group
(N = 69)

Spearman's rho

SDSCA
Composite
score
1.000

VFQ
Item 3
-0.153

VFQ Mental
Health
Score
-0.173

VFQ
Composite
Score
0.022

FCQ
Vision
Score
0.131

FCQ
Composite
Score
0.012

.

0.210

0.156

0.861

0.285

0.924

SDSCA
Composite
score

Correlation
Coefficient

VFQ Item 3

Correlation
Coefficient

-0.153

1.000

.889**

.446**

-.596**

-.636**

Sig. (2tailed)

0.210

.

0.000

0.000

0.000

0.000

VFQ Mental
Health
Score

Correlation
Coefficient

-0.173

.889**

1.000

.633**

-.517**

-.560**

Sig. (2tailed)

0.156

0.000

.

0.000

0.000

0.000

VFQ
Composite
Score

Correlation
Coefficient

0.022

.446**

.633**

1.000

-.343**

-.372**

Sig. (2tailed)

0.861

0.000

0.000

.

0.004

0.002

FCQ Vision
Score

Correlation
Coefficient

0.131

-.596**

-.517**

-.343**

1.000

.815**

Sig. (2tailed)

0.285

0.000

0.000

0.004

.

0.000

Correlation
Coefficient

0.012

-.636**

-.560**

-.372**

.815**

1.000

Sig. (2tailed)

0.924

0.000

0.000

0.002

0.000

.

FCQ
Composite
Score

Sig. (2tailed)

* Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
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Table 2d. Significant and non-Significant Spearman Correlations of Interest for the Unknown Diabetes Type
Group (N = 7)

Spearman's rho

VFQ Item
3
-0.468

VFQ
Mental
Health
Score
-0.099

VFQ
Composite
Score
-0.036

FCQ
Vision
Score
0.182

FCQ
Composite
Score
0.144

.

0.290

0.834

0.939

0.696

0.758

SDSCA
Composite
Score
1.000

SDSCA
Composite
Score

Correlation
Coefficient

VFQ Item 3

Correlation
Coefficient

-0.468

1.000

.774*

0.225

-0.686

-0.576

Sig. (2tailed)

0.290

.

0.041

0.628

0.089

0.176

VFQ Mental
Health
Score

Correlation
Coefficient

-0.099

.774*

1.000

0.571

-.903**

-.915**

Sig. (2tailed)

0.834

0.041

.

0.180

0.005

0.004

VFQ
Composite
Score

Correlation
Coefficient

-0.036

0.225

0.571

1.000

-0.491

-0.577

Sig. (2tailed)

0.939

0.628

0.180

.

0.263

0.175

FCQ Vision
Score

Correlation
Coefficient

0.182

-0.686

-.903**

-0.491

1.000

.963**

Sig. (2tailed)

0.696

0.089

0.005

0.263

.

0.000

Correlation
Coefficient

0.144

-0.576

-.915**

-0.577

.963**

1.000

Sig. (2tailed)

0.758

0.176

0.004

0.175

0.000

.

FCQ
Composite
Score

Sig. (2tailed)

* Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
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Table 2e. Significant and non-Significant Spearman Correlations of Interest for all Subjects Combined
(N=100)

Spearman's rho

VFQ
Item 3
-0.058

VFQ
Mental
Health
Score
-0.068

VFQ
Composite
Score
0.082

FCQ
Vision
Score
0.089

FCQ
Composite
Score
-0.035

.

0.565

0.503

0.419

0.381

0.727

SDSCA
Composite
Score
1.000

SDSCA
Composite
Score

Correlation
Coefficient

VFQ Item 3

Correlation
Coefficient

-0.058

1.000

.907**

.491**

-.585**

-.593**

Sig. (2tailed)

0.565

.

0.000

0.000

0.000

0.000

VFQ Mental
Health
Score

Correlation
Coefficient

-0.068

.907**

1.000

.657**

-.549**

-.560**

Sig. (2tailed)

0.503

0.000

.

0.000

0.000

0.000

VFQ
Composite
Score

Correlation
Coefficient

0.082

.491**

.657**

1.000

-.355**

-.373**

Sig. (2tailed)

0.419

0.000

0.000

.

0.000

0.000

FCQ Vision
Score

Correlation
Coefficient

0.089

-.585**

-.549**

-.355**

1.000

.806**

Sig. (2tailed)

0.381

0.000

0.000

0.000

.

0.000

Correlation
Coefficient

-0.035

-.593**

-.560**

-.373**

.806**

1.000

Sig. (2tailed)

0.727

0.000

0.000

0.000

0.000

.

FCQ
Composite
Score

Sig. (2tailed)

* Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
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Table 3a. Linear Regression Analysis - Relationship between VFQMental Health, VFQItem 3, VFQComposite,
FCQVision, FCQComposite Scores (as Independent Variables) and the SDSCAComposite Score (as the Dependent
Variable)
Independent
Variables

R square

Regression

Standardized Regression

Significance

Coefficient (B)

Coefficient (Bs)

(2 tailed)

Type 1 DM
VFQMental Health

0.059

0.092

0.242

0.254

VFQItem 3

0.231

0.118

0.481

0.017*

VFQComposite

0.041

0.091

0.203

0.340

FCQVision

0.021

-0.043

-0.144

0.501

FCQComposite

0.089

-0.131

-0.298

0.157

VFQMental Health

0.030

-0.188

-0.172

0.157

VFQItem 3

0.029

-0.092

-0.169

0.164

VFQComposite

0.011

-0.140

-0.106

0.385

FCQVision

0.015

0.064

0.122

0.316

FCQComposite

0.000

0.004

0.006

0.959

VFQMental Health

0.013

-0.100

-0.112

0.266

VFQItem 3

0.012

-0.052

-0.108

0.283

VFQComposite

0.002

-0.050

-.047

0.641

FCQVision

0.009

0.046

0.096

0.341

FCQComposite

0.000

-0.004

-0.006

0.953

Type 2 DM

All DM groups

Dependent variable: SDSCAComposite Score
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Table 3b. Multiple Regression Analysis - Effect of Fear of Other Diabetes Complications on the Relationship
between Concern for Overall Eyesight and Self-care Behavior (Type 1 Diabetes Group only).

Variable
VFQ Items

R square

Regression

Standardized Regression

Significance

coefficient (B)

Coefficient (Ba)

(2 tailed)

0.357

0.155

0.630

0.018*

FCQLong term

0.240

0.105

0.425

0.069

FCQVision

0.243

0.134

0.543

0.022*

FCQHeart

0.247

0.108

0.439

0.040*

FCQKidney

0.242

0.125

0.507

0.017*

FCQStroke

0.285

0.109

0.442

0.028*

FCQBlood Glucose

0.252

0.111

0.450

0.030*

FCQCirculation

0.275

0.093

0.378

0.083

FCQComposite

0.237

0.108

0.439

0.056

21,22,25,A12

Independent Variable: VFQItem 3 Score
Dependent Variable: SDSCAComposite Score
*Relationship between VFQItem 3 Score and SDSCAComposite Score remains statistically significant when indicated
continuous variables are controlled for.
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Table 4. ANCOVA - Determining the Effect of Confounding Variables on the Association between
VFQItem 3 scores and SDSCAComposite Scores.
F ratio

R2model

(dfM, dfR)

(ŋ2model)

None

6.620 (1,22)

Age

ŋ2VFQ_3

Effect size (r)

P

0.231

0.231

0.481

0.017*

6.198 (1,20)

0.290

0.220

0.486

0.022*

Gender

6.646 (1,21)

0.250

0.237

0.490

0.018*

Employment Statusa

2.973 (1,19)

0.342

0.103

0.368

0.101

Marital Status

6.162 91,21)

0.232

0.225

0.476

0.002*

Health Insurance

4.980 (1,16)

0.409

0.184

0.489

0.040*

Years of DM

6.329 (1,21)

0.249

0.166

0.481

0.020*

Type of Medication

6.756 (1,20)

0.510

0.166

0.502

0.017*

Diabetic Retinopathy

4.274 (1,21)

0.275

0.148

0.411

0.051

Laser Therapy for DR

4.650 (1,21)

0.241

0.168

0.425

0.043*

9.441 (1,21)

0.351

0.292

0.557

0.006*

All 10 factors

0.253 (1,4)

0.877

0.008

0.244

0.641

Macular Degeneration

7.573 (1,21)

0.267

0.265

0.515

0.012*

6.407 (1,21)

0.389

0.187

0.483

0.019*

Cataract

6.933 (1,21)

0.262

0.243

0.498

0.016*

Glaucoma

8.699 (1,21)

0.335

0.276

0.541

0.008*

Cataract Surgery

6.489 (1,21)

0.236

0.236

0.485

0.019*

All 8 eye-related factors

8.146 (1,14)

0.692

0.179

0.606

0.013*

Factor

Presbyopia (Glasses for
Near Vision)

Myopia (Glasses needed
for Distant Vision)

F-ratio: Ratio of the average variability in the data that each respect model can explain to the average variability
unexplained by the same model
ŋ2model : Total variance of each respective model
ŋ2VFQ_3: Proportion of variance in SDSCAComposite score attributable to VFQItem 3 score in each respective model
Effect size (r): Effect size of VFQItem 3 score in each respective model
P: Statistical significance of the relationship between VFQItem 3 and SDSCAComposite scores in each respective model
Dependent Variable: SDSCAComposite Score
Independent Variable: VFQItem 3 Score
*Relationship between SDSCAComposite score and VFQItem 3 score remains statistically significant with the indicated
categorical variables are adjusted for.
aLevene's test of equality of variances not met.
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Table 5a. Relationship Between HgA1c and SDSCAComposite, FCQComposite, FCQVision, VFQMental Health and
VFQComposite Scores
F-ratioCombined
(dfM, dfR)

F-ratioLinear
Sig. (2-tailed)

(dfM, dfR)

Sig. (2-tailed)

Type 1 DM
SDSCAComposite

0.319 (4,15)

0.861

0.106 (1,15)

0.749

FCQComposite

0.310 (4,15)

0.867

0.003 (1,15)

0.957

FCQVision

0.760 (4, 15)

0.567

1.76 (1,15)

0.205

VFQMental Health

1.02 (4,15)

0.430

0.352 (1, 15)

0.562

VFQComposite

1.72 (4,15)

0.198

0.353 (1, 15)

0.561

0.994 (4,53)

0.419

0.234 (1,53)

0.631

FCQComposite

5.94 (4,53)

0.001*

7.80 (1,53)

0.007*

FCQVision

5.06(4,53)

0.002*

7.56 (1,53)

0.008*

VFQMental Health

1.25 (4,53)

.300

0.443 (1,53)

0.509

VFQ Composite

0.682 (4,53)

.607

0.394 (1,53)

0.533

All Groups Combined
SDSCAComposite

0.680 (4, 79)

0.608

0.141 (1, 79)

0.708

FCQComposite

2.601 (4, 79)

0.042*

2.994 (1, 79)

0.087

1.58 (4, 79)

0.188

0.835 (1, 79)

0.364

VFQMental Health

0.621 (4, 79)

0.649

0.847 (1, 79)

0.360

VFQComposite

0.267 (4, 79)

0.898

0.832 (1, 79)

0.364

Type 2 DM
SDSCAComposite

FCQVision

*Statistically Significant
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Table 5b. Effect sizes of Relationships between FCQ Composite and Subscale Scores and HgA1c levels for the Type 2
Diabetic group and all Groups Combined.

FCQ Subscale Score

F-ratioCombined

F-ratioLinear

(dfM, dfR, sig)

(dfM, dfR, sig)

Effect size (ω)

Type 2 DM
5.942 (4, 53, 0.003*)

7.80 (1, 53, 0.007*)

0.504*

FCQBlood Glucose

5.88 (4, 53, 0.001*)

9.60 (1, 53, 0.003*)

0.502*

FCQVision

5.06 (4, 53, 0.002*)

7.56 (1, 53, 0.008*)

0.468*

FCQStroke

5.00 (4, 53, 0.002*)

5.47 (1, 53, 0.023*)

0.465*

FCQLong Term

4.67 (4, 53, 0.003*)

5.78 (1, 53, 0.020*)

0.449*

FCQ Heart

4.80 (4, 53, 0.002*)

5.88 (1, 53, 0.019*)

0.445*

FCQKidney

2.88 (4, 53, 0.031*)

3.77 (1, 53, 0.058)

0.339*

2.00 (4, 53, 0.108)

1.03 (1, 53, 0.314)

0.254

FCQComposite

2.60 (4, 79, 0.042*)

2.99 (1, 79, 0.087)

0.283*

FCQBlood Glucose

3.09 (4, 79, 0.020*)

5.34 (1, 79, 0.023*)

0.323*

FCQStroke

4.83 (4, 79, 0.002*)

1.81 (1, 79, 0.182)

0.437*

FCQComposite

FCQCirculation
All DM Groups

*Statistically Significant
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Table 5c. Planned Contrast Results for Comparison of FCQ Composite and Subscale Scores Between
HgA1c Categories in the Type 2 Diabetes Group and All Groups Combined.

FCQ Subscale
Score

Value of

Std.

Contrast

Contrasta

Contrast

Error

1

83.83

46.44

1.805

4

42.54

12.06

1

105.39

4

t

dfR

Sig. (2-tailed)

Effect size (r)

53

0.077

0.241

3.527

53

0.001*

0.436*

52.44

2.009

53

0.050*

0.266*

52.36

13.62

3.843

53

<0.001*

0.467*

1

96.61

50.38

1.918

53

0.061

0.255

4

47.98

13.09

3.667

53

0.001*

0.450*

1

100.20

57.51

1.742

53

0.087

0.233

4

38.27

14.94

2.562

53

0.013*

0.332*

1

88.75

46.84

1.895

53

0.064

0.252

4

45.79

12.17

3.763

53

<0.001*

0.459*

1

118.29

50.59

2.338

53

0.023*

0.306*

4

53.37

13.14

4.062

53

<0.001*

0.487*

1

89.17

41.43

2.153

53

0.036*

0.284*

4

44.85

10.76

4.168

53

<0.001*

0.497*

1

48.7

37.7

1.290

79

0.201

0.144

4

25.9

9.32

2.775

79

0.007*

0.298*

1

40.50

40.94

0.989

79

0.326

0.111

4

38.16

10.12

3.772

79

<0.001*

0.391*

1

80.13

47.85

1.675

79

0.098

0.185

4

33.18

11.82

2.806

79

0.006*

0.301*

Type 2 DM
FCQLong term

FCQVision

FCQHeart

FCQKidney

FCQStroke

FCQBlood Glucose

FCQComposite

All DM Groups
FCQComposite

FCQStroke

FCQBlood Glucose

* Statistically significant
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aContrast

Coefficients
What was your most recent HbA1c level?

Contrast

<5.0 - 5.9

6.0 - 6.9

7.0 - 7.9

8.0-9.0

>9.0

1

-4

1

1

1

1

2

0

-3

1

1

1

3

0

0

-2

1

1

4

0

0

0

-1

1
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8. Figures
Figure 1. Linear Regression Relationship Between VFQItem 3 and SDSCAComposite Score for the Type 1
Diabetes Group
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9. APPENDIX: QUESTIONNAIRES
I.

Demographic Information Sheet

Please complete the following questions as best you can to help us learn more about who you are. Note that
none of the information you provide will be shared with unauthorized individuals. Thank you for your
participation.
1. Have you participated in this study before?
a. Yes
b. No
If ‘Yes’ please return the questionnaire packet to the individual who gave it to you.
2. What is your age? ________________years.
3. What is your gender?
a. Male
b. Female
4. What language do you speak most in your home?
a. English
b. Spanish
c. Other (please specify):_______________________
5. What is the highest level of formal education you have completed?
a. Elementary school
b. High school or equivalent
c. Vocation/Technical School (2 years)
d. Some College
e. Bachelor’s Degree (4 years of College)
f. Master’s Degree
g. Doctoral Degree or equivalent
h. Professional Degree (MD, JD etc)
i. Other (please specify):_________________________
6. What is your race?
a. African American
b. Asian
c. Caucasian
d. Hispanic
e. Multi-racial
f. Other (please specify):________________________
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7. How would you describe your current employment status?
a. Employed (full time)
b. Employed (part time)
c. Unemployed (but job hunting)
d. Unemployed (not job hunting)
e. Disabled ( unable to work)
f. Retired
8. What is your yearly income level?
a.
<$30,000
b.
$30,000 - $60,000
c.
$60,000 - $100,000
d.
$100,000 and greater
9. What is your current marital status?
a. Single
b. Married
c. Divorced
d. Separated
e. Widowed
f. Civil union
g. Living with another

10. What kind of health insurance do you have (Please circle one)?
a. Medicare only
b. Medicaid only
c. Private only
d. Medicare and Medicaid
e. Medicare and Private
f. Medicaid and Private
g. None/self pay
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II. Health Information Sheet
Please complete this questionnaire as best you can to help us understand more about your health. Note
that none of the information you provide will be shared with unauthorized individuals. Thank you for your
participation.
1.
a.
b.
c.
d.
e.

What type of diabetes do you have?
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Other (Please specify):____________________________________
Don’t know

2. When were you first told you have diabetes? (Circle one)
Less than 5 years ago/5-10 years ago/10-20 years ago/More than 20 years ago
3.

Are you using any medication for diabetes?

Yes

No Don’t know

Yes

No Don’t know

Yes

No Don’t know

Yes

No Don’t know

Yes

No Don’t know

4. If you answered ‘Yes’ to question (3), what kind of medication are you using?
(Circle all that apply)
a. Pills/tablets
b. Injection (Insulin)
c. Pump (Insulin)
d. Other (Please Specify):___________________________________
e. Don’t know
5.
a.
b.
c.
d.
e.
f.
g.

What was your most recent HbA1c level (within the past 2-3 months)?
< 5.0
5.0 – 5.9
6.0 – 6.9
7.0 – 7.9
8.0 – 9.0
> 9.0
Don’t know

6.

Have you ever been told you have kidney problems because of diabetes?

7. If you answered ‘Yes’ to question (6) please answer the following:
a. Are you on dialysis?
b. Have you ever received a kidney transplant?
8.

Have you ever been told you have diabetic retinopathy or diabetic eye
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disease?
a. If ‘Yes’ have you ever had laser treatments for your diabetic eye disease?

Yes

No Don’t know

Yes

No Don’t know

10. Do you wear glasses to help you see things up close?

Yes

No Don’t know

11. Have you ever been told you have macular degeneration?

Yes

No Don’t know

13. Have you ever been told you have cataracts or clouded eye lenses?

Yes

No Don’t know

14. If you answered ‘Yes’ to question (13), have you ever had surgery to have the
cataracts removed?

Yes

No Don’t know

15. Have you ever been told you have glaucoma or high eye pressure?

Yes

No Don’t know

18. Have you ever had an eye examination that included having eye drops put in
your eyes to dilate your pupils?

Yes

No Don’t know

19. Have you ever had a stroke?

Yes

No Don’t know

20. Have you ever been told you have heart disease?

Yes

No Don’t know

9.

Do you wear glasses to help you see things that are far away?

12. If you answered ‘Yes’ to question (11), have you received or do you use any of
the following treatments? (Circle all that apply)
a. Vitamins (taken by mouth)
b. Injections into the eye
c. Laser therapy
d. Other ( Please Specify): _________________________
e. Don’t know

16. If you answered ‘Yes’ to question (15), have you received or do you use any of
the following treatments? (Circle all that apply)
a. Eye drops
b. Surgery
c. Laser therapy
d. Other (Please specify):______________________________
e. Don’t know
17.
a.
b.
c.
d.
e.

When was your last eye examination? (circle one)
I have never had an eye exam
Within the last year
2 – 5 years ago
Greater than 5 years ago
I cannot remember
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21. If you answered ‘Yes’ to question (20) please answer the following:
a.

Have you ever had a heart attack?

Yes

No Don’t know

b.

Do you experience chest pain when you exercise or walk long distances?

Yes

No Don’t know

22. Have you ever been told you have poor circulation?

Yes

No Don’t know

23. If you answered ‘Yes’ to question (19) please answer the following:
a. Do you have sores on your legs/feet that do not heal?

Yes

No Don’t know

Yes

No Don’t know

Yes

No Don’t know

b. Has any part of your body been amputated because of poor circulation?
24. Does anyone in your family have diabetes?
25. If you answered ‘Yes’ to question (24) please answer the following:
a. Please specify how this (these) family member(s) is(are) related to you (e.g.
mother, brother, sister etc) :______________________________
b. Has (have) this (these) family members experienced any of the following
diabetes complications?
i. Heart disease
ii. Kidney disease
iii. Diabetic retinopathy/diabetic eye disease
iv. Stroke
v. Blindness
vi. Amputation of a limb
vii. Other (Please specify): _______________________
viii. Don’t know
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III. Summary of Diabetes Self-Care Activities
The questions below ask you about your diabetes self-care activities during the past 7 days. If you were
sick during the past 7 days, please think back to the last 7 days that you were not sick.
Diet
1. How many of the last SEVEN DAYS have you followed a healthy eating plan?
0
1
2
3
4
5

6

2. On average, over the past month, how many DAYS PER WEEK have you followed your eating
plan?
0
1
2
3
4
5
6

7

7

3. On how many of the last SEVEN DAYS did you eat five or more servings of fruits and vegetables?
0
1
2
3
4
5
6
7
4. On how many of the last SEVEN DAYS did you eat high fat foods such as red meat or full-fat dairy
products?
0
1
2
3
4
5
6
7

Exercise
5. On how many of the last SEVEN DAYS did you participate in at least 30 minutes of physical
activity? (Total minutes of continuous activity, including walking).
0
1
2
3
4
5
6

7

6. On how many of the last SEVEN DAYS did you participate in a specific exercise session (such as
swimming, walking, biking) other than what you do around the house or as part of your work?
0
1
2
3
4
5
6
7
Blood Sugar Testing
7. On how many of the last SEVEN DAYS did you test your blood sugar?
0
1
2
3
4
5

6

8. On how many of the last SEVEN DAYS did you test your blood sugar the number of times
recommended by your health care provider?
0
1
2
3
4
5
6

7

7

Foot Care
9. On how many of the last SEVEN DAYS did you check your feet?
0
1
2
3
4

5

6

7
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10. On how many of the last SEVEN DAYS did you inspect the inside of your shoes?
0
1
2
3
4
5

6

7

Smoking
11. Have you smoked a cigarette—even one puff—during the past SEVEN DAYS?
0. No
1. Yes.
If Yes, how many cigarettes did you smoke on an average day?
Number of cigarettes:
Medications
12. On how many of the last SEVEN DAYS, did you take your recommended diabetes medication?
0
1
2
3
4
5
6

7
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IV. Fear of complications questionnaire (FCQ)
This questionnaire is designed to help us understand how you feel about your Diabetes and how it affects
you, particularly in the long-term. Please answer the following questions as honestly as possible. Your
answers will be kept in strictest confidence.

1.

I feel afraid of long-term complications of Diabetes
Very

Moderately

A little

Not at all

Occasionally

Never

2. I worry about losing my eyesight because of Diabetes
All the time
3.

Frequently

I worry that having Diabetes increases my chances of heart disease
All the time

Frequently

Occasionally

Never

A little

Not at all

4. I am afraid I will need a kidney transplant one day
Very

5.

I am afraid of developing long-term complications as a result of frequent high blood sugars
All the time

6.

Moderately

Frequently

Occasionally

Never

I am afraid that I may need kidney dialysis one day
Never

Occasionally

Frequently

Constantly
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7.

I am afraid that I will develop kidney problems one day
All the time

8.

Occasionally

Never

Occasionally

Frequently

All the time

Occasionally

Frequently

Constantly

Occasionally

Frequently

All the time

A little

Not at all

Moderately scared

Very scared

Moderately

I'm scared of having a heart attack in the future
Not at all

15.

Frequently

I am scared that Diabetes could affect my feet
Very

14.

All the time

Do you worry about future problems when your blood sugars are erratic?
Not at all

13.

Frequently

I worry that the Diabetes Specialist will find something wrong with my eyes
Not at all

12.

Occasionally

Do you ever worry about your future health?
Not at all

11.

Never

I worry that I might be at a higher risk for having a stroke
All the time

10.

Occasionally

How often do you think about long-term complications of Diabetes?
Hardly ever

9.

Frequently

A little scared

I worry about developing problems with circulation
Never

Occasionally

Frequently

All the time
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V.

Visual Functioning Questionnaire (VFQ)
PB/IA

National Eye Institute Visual
Functioning Questionnaire - 25
(VFQ-25)
version 2000

(INTERVIEWER ADMINISTERED FORMAT)

January 2000

RAND hereby grants permission to use the "National Eye Institute Visual Functioning Questionnaire 25 (VFQ-25)
July 1996, in accordance with the following conditions which shall be assumed by all to have been agreed to as a
consequence of accepting and using this document:
1. Changes to the NEI VFQ-25 - July 1996 may be made without the written permission of RAND. However, all
such
changes shall be clearly identified as having been made by the recipient.
2. The user of this NEI VFQ-25 - July 1996 accepts full responsibility, and agrees to hold RAND harmless, for the
accuracy of any translations of the NEI VFQ-25 Test Version - July 1996 into another language and for any errors,
omissions, misinterpretations, or consequences thereof.
3. The user of this NEI VFQ-25 - July 1996 accepts full responsibility, and agrees to hold RAND harmless, for any
consequences resulting from the use of the NEI VFQ-25.
4. The user of the NEI VFQ-25 - July 1996 will provide a credit line when printing and distributing this document
or
in publications of results or analyses based on this instrument acknowledging that it was developed at RAND
under
the sponsorship of the National Eye Institute.
5. No further written permission is needed for use of this NEI VFQ-25 - July 1996.
7/29/96

© R 1996
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Instructions:
I’m going to read you some statements about problems which involve your vision
or feelings that you have about your vision condition. After each question I will
read you a list of possible answers. Please choose the response that best
describes your situation.
Please answer all the questions as if you were wearing your glasses or contact
lenses (if any).
Please take as much time as you need to answer each question. All your
answers are confidential. In order for this survey to improve our knowledge
about vision problems and how they affect your quality of life, your answers must
be as accurate as possible. Remember, if you wear glasses or contact lenses
for a particular activity, please answer all of the following questions as though
you were wearing them.
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Visual Functioning Questionnaire - 25
PART 1 - GENERAL HEALTH AND VISION
1. In general, would you say your overall health is*:
(Circle One)
Excellent

READ CATEGORIES:
........................... 1

Very Good......................... 2
Good.................................. 3
Fair..................................... 4
Poor................................... 5

2. At the present time, would you say your eyesight using both eyes
(with glasses or contact lenses, if you wear them) is excellent, good,
fair, poor, or very poor or are you completely blind?
(Circle One)
Excellent

READ CATEGORIES:
........................... 1

Good.................................. 2
Fair..................................... 3
Poor................................... 4
Very Poor .......................... 5
Completely Blind.............. 6

______________________
* Skip Question 1 when the VFQ-25 is administered at the same time as the SF-36 or
RAND 36-Item Health Survey 1.0
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3. How much of the time do you worry about your eyesight?
(Circle One)
None of the time.......................... 1
A little of the time........................ 2
Some of the time......................... 3
Most of the time .......................... 4
All of the time? ............................ 5

READ CATEGORIES:

4. How much pain or discomfort have you had in and around your eyes
(for example, burning, itching, or aching)? Would you say it is:
(Circle One)
None

READ CATEGORIES:
.................................. 1

Mild.................................... 2
Moderate ........................... 3
Severe, or.......................... 4
Very severe?..................... 5

PART 2 - DIFFICULTY WITH ACTIVITIES
The next questions are about how much difficulty, if any, you have doing
certain activities wearing your glasses or contact lenses if you use them
for that activity.
5. How much difficulty do you have reading ordinary print in
newspapers? Would you say you have:
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6
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6. How much difficulty do you have doing work or hobbies that require
you to see well up close, such as cooking, sewing, fixing things
around the house, or using hand tools? Would you say:
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6

7. Because of your eyesight, how much difficulty do you have finding
something on a crowded shelf?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6

8. How much difficulty do you have reading street signs or the names of
stores?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6
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9. Because of your eyesight, how much difficulty do you have going
down steps, stairs, or curbs in dim light or at night?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6

10. Because of your eyesight, how much difficulty do you have noticing
objects off to the side while you are walking along?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6

11. Because of your eyesight, how much difficulty do you have seeing
how people react to things you say?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6
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12. Because of your eyesight, how much difficulty do you have picking
out and matching your own clothes?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6

13. Because of your eyesight, how much difficulty do you have visiting
with people in their homes, at parties, or in restaurants ?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ...................................... 6

14. Because of your eyesight, how much difficulty do you have going out
to see movies, plays, or sports events?
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................................... 1
A little difficulty...................................................... 2
Moderate difficulty................................................. 3
Extreme difficulty................................................... 4
Stopped doing this because of your eyesight .... 5
Stopped doing this for other reasons or not
interested in doing this ..................................... 6
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15. Now, I’d like to ask about driving a car. Are you currently driving, at
least once in a while?
(Circle One)
Yes .................... 1 Skip To Q 15c
No...................... 2

15a. IF NO, ASK: Have you never driven a car or have you given up
driving?
(Circle One)
Never drove ...... 1 Skip To Part 3, Q 17
Gave up............. 2

15b. IF GAVE UP DRIVING: Was that mainly because of your
eyesight, mainly for some other reason, or because of both your
eyesight and other reasons?
(Circle One)
Mainly eyesight ................................ 1 Skip To Part 3, Q 17
Mainly other reasons ....................... 2 Skip To Part 3, Q 17
Both eyesight and other reasons ... 3 Skip To Part 3, Q 17

15c. IF CURRENTLY DRIVING: How much difficulty do you have
driving during the daytime in familiar places? Would you say
you have:
(Circle One)
No difficulty at all ............................. 1
A little difficulty ................................ 2
Moderate difficulty ........................... 3
Extreme difficulty ............................. 4
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16. How much difficulty do you have driving at night? Would you say you
have: (READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................... 1
A little difficulty...................................... 2
Moderate difficulty................................. 3
Extreme difficulty................................... 4
Have you stopped doing this because
of your eyesight ................................ 5
Have you stopped doing this for other
reasons or are you not interested in
doing this .......................................... 6

16a. How much difficulty do you have driving in difficult conditions, such
as in bad weather, during rush hour, on the freeway, or in city traffic?
Would you say you have:
(READ CATEGORIES AS NEEDED)
(Circle One)
No difficulty at all................................... 1
A little difficulty...................................... 2
Moderate difficulty................................. 3
Extreme difficulty................................... 4
Have you stopped doing this because
of your eyesight ................................ 5
Have you stopped doing this for other
reasons or are you not interested in
doing this .......................................... 6
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PART 3: RESPONSES TO VISION PROBLEMS
The next questions are about how things you do may be affected by your
vision. For each one, I’d like you to tell me if this is true for you all, most,
some, a little, or none of the time.
(Circle One On Each Line)
READ CATEGORIES:

17. Do you accomplish less
than you would like
because of your vision?
18. Are you limited in how
long you can work or do
other activities because of
your vision? ...................
19. How much does pain or
discomfort in or around
your eyes, for example,
burning, itching, or
aching, keep you from
doing what you’d like to
be doing? Would you say:

All of
the time

Most of
the time

Some
of the
time

A little
of the
time

None of
the time

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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For each of the following statements, please tell me if it is definitely true,
mostly true, mostly false, or definitely false for you or you are not sure.
(Circle One On Each Line)
READ CATEGORIES:

Definitely
True

Mostly
True

Not
Sure

Mostly
False

Definitely
False

20. I stay home most of the time
because of my eyesight.....

1

2

3

4

5

21. I feel frustrated a lot of the
time because of my eyesight J.

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

22. I have much less control
over what I do, because of
my eyesight. .......................
23. Because of my eyesight, I
have to rely too much on
what other people tell me. .
24. I need a lot of help from
others because of my
eyesight...............................
25. I worry about doing things
that will embarrass myself
or others, because of my
eyesight...............................
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SUBSCALES: WELL-BEING/DISTRESS (#A12)
The next questions are about how you deal with your vision. For each
statement, please tell me if it is definitely true, mostly true, mostly false, or
definitely false for you or you don’t know.
(Circle One On Each Line)
READ CATEGORIES:
A12. I am often irritable because
of my eyesight. ...................

Definitely
True
1

Mostly
True
2

Not
Sure
3

Mostly
False

Definitely
False

4

That’s the end of the interview. Thank you very much for your
time and your help.
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